Tecovirimat is effective against human monkeypox virus in vitro at nanomolar concentrations
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tecovirimat is effective against human monkeypox virus in vitro at nanomolar concentrations
Authors
Keywords
-
Journal
Nature Microbiology
Volume 7, Issue 12, Pages 1951-1955
Publisher
Springer Science and Business Media LLC
Online
2022-11-08
DOI
10.1038/s41564-022-01269-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Epidemiological, clinical and virological characteristics of four cases of monkeypox support transmission through sexual contact, Italy, May 2022
- (2022) Andrea Antinori et al. Eurosurveillance
- Clinical features and management of human monkeypox: a retrospective observational study in the UK
- (2022) Hugh Adler et al. LANCET INFECTIOUS DISEASES
- Estimated incubation period for monkeypox cases confirmed in the Netherlands, May 2022
- (2022) Fuminari Miura et al. Eurosurveillance
- Demographic and clinical characteristics of confirmed human monkeypox virus cases in individuals attending a sexual health centre in London, UK: an observational analysis
- (2022) Nicolò Girometti et al. LANCET INFECTIOUS DISEASES
- Phylogenomic characterization and signs of microevolution in the 2022 multi-country outbreak of monkeypox virus
- (2022) Joana Isidro et al. NATURE MEDICINE
- Case 24-2022: A 31-Year-Old Man with Perianal and Penile Ulcers, Rectal Pain, and Rash
- (2022) Nesli Basgoz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Urgent need for a non-discriminatory and non-stigmatizing nomenclature for monkeypox virus
- (2022) Christian Happi et al. PLOS BIOLOGY
- Drug development against smallpox: present and future.
- (2020) Déborah Delaune et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- IQ-TREE 2: New Models and Efficient Methods for Phylogenetic Inference in the Genomic Era
- (2020) Bui Quang Minh et al. MOLECULAR BIOLOGY AND EVOLUTION
- Nextstrain: real-time tracking of pathogen evolution
- (2018) James Hadfield et al. BIOINFORMATICS
- Oral Tecovirimat for the Treatment of Smallpox
- (2018) Douglas W. Grosenbach et al. NEW ENGLAND JOURNAL OF MEDICINE
- UFBoot2: Improving the Ultrafast Bootstrap Approximation
- (2017) Diep Thi Hoang et al. MOLECULAR BIOLOGY AND EVOLUTION
- ST-246 is a key antiviral to inhibit the viral F13L phospholipase, one of the essential proteins for orthopoxvirus wrapping
- (2015) Sophie Duraffour et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Human Monkeypox
- (2013) A. M. McCollum et al. CLINICAL INFECTIOUS DISEASES
- MAFFT Multiple Sequence Alignment Software Version 7: Improvements in Performance and Usability
- (2013) K. Katoh et al. MOLECULAR BIOLOGY AND EVOLUTION
- Progressive Vaccinia: Case Description and Laboratory-Guided Therapy With Vaccinia Immune Globulin, ST-246, and CMX001
- (2012) E. R. Lederman et al. JOURNAL OF INFECTIOUS DISEASES
- Real-time PCR assays for the specific detection of monkeypox virus West African and Congo Basin strain DNA
- (2010) Yu Li et al. JOURNAL OF VIROLOGICAL METHODS
- ST-246 Antiviral Efficacy in a Nonhuman Primate Monkeypox Model: Determination of the Minimal Effective Dose and Human Dose Justification
- (2009) R. Jordan et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Nonhuman Primates Are Protected from Smallpox Virus or Monkeypox Virus Challenges by the Antiviral Drug ST-246
- (2009) J. Huggins et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Evaluation of orally delivered ST-246 as postexposure prophylactic and antiviral therapeutic in an aerosolized rabbitpox rabbit model
- (2008) Aysegul Nalca et al. ANTIVIRAL RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search